医学全在线
医学全在线首页-医师-药师-护士-卫生资格-高级职称-考试题库-网校-考研-图谱-下载-招聘  
分类
国家级省级浙江省各省杂志
科技核心北大核心CSCDCSCD扩展
工具
期刊知识写作指导 论文投稿推荐期刊
期刊验证论文检测 录用通知往期目录
SCI
SCI指导影响因子
期刊点评基金动态
其它
经济教育计算机
建筑体育农业
北京|天津|河北|山西|湖北|江苏|安徽|山东|上海|浙江|江西|福建|湖南|宁夏|内蒙古|河南
四川|重庆|贵州|云南|辽宁|吉林|广东|广西|海南|陕西|甘肃|新疆|青海|卫生部直属|黑龙江|兵团
您现在的位置: 医学全在线 > 医学论文 > 论文投稿 > 正文:医学免费论文:布托啡诺与舒芬太尼联合用于食管肿瘤切除术后患者自控静脉镇痛的效果
    

医学免费论文:布托啡诺与舒芬太尼联合用于食管肿瘤切除术后患者自控静脉镇痛的效果

来源:本站原创 更新:2013-10-9 论文投稿平台

医学免费论文:布托啡诺与舒芬太尼联合用于食管肿瘤切除术后患者自控静脉镇痛的效果

【摘要】 目的 研究布托啡诺与舒芬太尼联合应用于食管肿瘤切除术后患者自控静脉镇痛(patient-controlled intravenous analgesia,PCIA)的临床效果及其安全性。方法 60例ASAⅠ~Ⅲ级的食管肿瘤患者,随机均分为3组行PCIA。B组:布托啡诺0.15 mg/kg;S组:舒芬太尼2 μg /kg;BS组(布托啡诺0.075 mg/kg+舒芬太尼1 μg/kg)。监测并记录术后4、12、24、48 h患者的镇痛(VAS评分)和镇静(Ramsay评分)效果及副作用发生情况。结果 3组镇痛效果均确切可靠。B组VAS评分显著高于S组和BS组 (P<0.05);S组和BS组之间差异无显著性(P>0.05)。B组患者Ramsay评分显著高于S组和BS组(P<0.05);S组和BS 组之间差异无显著性(P>0.05)。BS组不良反应发生例数显著低于其余两组(P<0.05)。结论 布托啡诺与舒芬太尼联合应用于食管肿瘤术后PCIA,镇痛效果确切可靠而不良反应少,是一种理想的镇痛方式。

【关键词】 布托啡诺;舒芬太尼;患者自控静脉镇痛

Efficiency of patient-controlled intravenous analgesia with butorphanol and

sufentanil following resection of esophageal carcinoma

JIAO Hao, QI Dunyi, LIU Gongjian

(Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221002, China)

Abstract: Objective To evaluate the efficacy and safety of butorphanol and sufentanil in patient-controlled intravenous analgesia (PCIA) subsequent to esophageal carcinoma resection. Methods 60 ASA Ⅰ to Ⅲ patients undergoing elective resection for esophageal carcinoma were randomized into 3 groups, who received PCIA with 0.15 mg/kg butorphanol (group B), 2 μg/kg sufentanil (group S) and 0.075 mg/kg butorphanol with 1 μg/kg sufentanil (group BS), respectively. The efficacy and side effects were evaluated by VAS scores and Ramsay scores at 4, 12, 24, 48 hours after operation. Results All the patients showed good relief with PCIA, but VAS scores of group B was significantly higher than those of groups S and BS (P<0.05). There were no significant differences in VAS scores between group S and group BS (P>0.05). The Ramsay scores of group B were significantly higher than those of group S and group BS (P<0.05). There were no significant differences in Ramsay scores between group S and group BS (P>0.05). The prevalence of side effects in group BS was significantly lower than that in other groups. Conclusion Butorphanol combined with sufentanyl in PCIA exhibits good effect of analgesia and minor adverse reactions; which enables a safer and more effective method of analgesia医.学全.在.线网站www.med126.com.

Key words: butorphanol; sufentanyl; patient-controlled intravenous analgesia


[1] [2] [3] 下一页

...
关于我们 - 联系我们 -版权申明 -诚聘英才 - 网站地图 - 网络课程 - 帮助
医学全在线 版权所有© CopyRight 2006-2046, MED126.COM, All Rights Reserved
浙ICP备12017320号
百度大联盟认证绿色会员实名网站 360认证可信网站 中网验证